FDA Puts X-Ray Gadget in Safety Timeout Category
Published Date: 6/2/2025
Rule
Summary
The FDA is officially putting the radiological acquisition and/or optimization guidance system into a special safety category called Class II. This means the device will have clear rules to keep it safe and effective, helping patients get better tech faster. If you make or use these devices, expect smoother approvals and more innovation coming your way soon!
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Class II: Clear Rules for Makers
The FDA is classifying the radiological acquisition and/or optimization guidance system into Class II (special controls). This puts specific special controls into the device's codified classification and is intended to reduce regulatory burdens, which should make approvals smoother for companies that make these devices.
Faster Access to Safe Radiology Tech
The FDA determined that Class II (special controls) for this device type will provide a reasonable assurance of safety and effectiveness. The Agency also states this classification is expected to enhance patients' access to beneficial innovative devices by reducing regulatory burdens, which may help patients get updated radiology technology sooner.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
Previous / Next Documents
Previous: 2025-09777 — Special Local Regulations; Marine Events Within the Fifth Coast Guard District-Cape May, NJ
On June 22, 2025, the Coast Guard will set special rules for the Around the Island Paddle event near Cape May, NJ to keep everyone safe on the water. Boat operators in the area must follow instructions from Coast Guard patrols, and anyone not part of the event needs permission to enter. This means some waterway access will be limited for a short time, but it’s all about making sure the event goes smoothly and safely.
Next: 2025-09856 — Revocation of Class D and Class E4 Airspace; Establishment of Class E2 Airspace; Amendment of Class E5 Airspace, Aberdeen, MD
Phillips Army Airfield in Aberdeen, MD is changing its airspace rules because its control tower closed. They’re removing some old airspace zones and creating a new one to keep flights safe, especially for pilots flying by instruments. These updates also adjust nearby airspace after a navigation beacon was turned off, with no extra costs or delays expected.